🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wimolnut Manheng

United States Food and Drug Administration

ORCID: 0000-0003-3909-086X

Also affiliated with Center for Drug Evaluation and Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer.

108 citations

Mirat Shah, Gwynn Ison, Haley Gittleman, Mallorie H. Fiero, Ankit Shah +20 more

3 citations

Kristine L. Witt, Helen Cunny, Dori R. Germolec, Daven N. Jackson‐Humbles, David E. Malarkey +12 more

N/A
0DataRank · unranked
3 citations

Dori R. Germolec, Victor J. Johnson, Travis V. Gulledge, Wimolnut Manheng, Kimber L. White +5 more

10 citations

Paul Rogers, Angel Paredes, Wimolnut Manheng, Beverly Lyn‐Cook, Tariq Fahmi +1 more

0 citations

Dow-Chung Chi, Sundeep Agrawal, Hee‐Koung Joeng, Sarah Kim-McOlash, Wimolnut Manheng +17 more